Veterinary research.
Publisher:
Editions Scientifiques Elsevier ; INRA,. London : BioMed Central (2011)
Frequency: Bimonthly
Country: England
Language: English
Author(s):
Institut national de la recherche agronomique (France)
Start Year:1993 -
ISSN:
0928-4249 (Print)
1297-9716 (Electronic)
0928-4249 (Linking)
1297-9716 (Electronic)
0928-4249 (Linking)
Impact Factor
4.4
2022
| NLM ID: | 9309551 |
| (DNLM): | SR0077159(s) |
| (OCoLC): | 27944714 |
| Coden: | VEREEM |
| LCCN: | sn 93015360 |
| Classification: | W1 VE934J |
Cardio-respiratory, haematological and biochemical parameter adjustments to exercise: effect of a probiotic in horses during training. Two randomly distributed groups of thoroughbred horses were compared during a 12-week period for their cardio-respiratory and metabolic adjustment to strenuous exercise, training and detraining. The horses were trained following the same standardized schedule and were regularly investigated using standardized treadmill exercise tests (SET) of increasing speed. After the first SET and during the whole experimental period, a group of 6 horses received a probiotic (Bioracing) once a day while a group of 5 horses received a placebo. All other conditions were similar for both groups. During each SE...
Kinetics and haematological effects of erythropoietin in horses. A plasma kinetic study of erythropoietin (EPO) was carried out in 4 horses after subcutaneous administration (30 IU/kg bwt) of recombinant human erythropoietin (rhEPO). At standardized intervals for 48 h before injection and for 60 h post-administration, the EPO plasma levels were determined with an immunoradiometric assay based on a sandwich technique. The peak plasma concentration (30-113 mIU/ml) was observed after a delay ranging from 6 to 9 h post-administration and the drug levels reached a physiological value around 60 h following rhEPO injection. Moreover, reference values for plasma EP...
Current status of the diagnosis and control of African horse sickness. African horse sickness (AHS) is an infectious, non-contagious, highly fatal viral disease of Equidae, transmitted by arthropod vectors of the genus Culicoides, and endemic in Africa south and east of the Sahara. The disease is caused by a virus of the Reoviridae family, genus Orbivirus, and 9 serotypes have been recognized. Recent outbreaks of AHS in the Iberian peninsula and Northern Africa emphasize the need for accurate diagnosis and rapid implementation of control measures. In this paper, the epizootiological factors, clinical signs and necropsy findings of AHS are discussed, and an update...
[Biological and parasitic variations in horses infested and reinfested by Trichinella spiralis]. Seven mares were infected with 20,000 Trichinella spiralis larvae; 2 of them were reinfected 22 wk later with the same amount of larvae. The course of infection in horses was assessed by serology (ELISA), biochemistry (aldolase activity), parasitology and histopathology. In each animal, infection was followed by a significant rise in specific antibody titers culminating at 5-10 wk post-infection (pi) and decreasing thereafter. Reinfection was followed by a slight rise in antibody levels. Aldolase activity increased during the first infection, but was not modified by reinfection. The parasite b...
African horse sickness: transmission and epidemiology. African horse sickness (AHS) virus causes a non-contagious, infectious, arthropod-borne disease of equines and occasionally of dogs. The virus is widely distributed across sub-Saharan African where it is transmitted between susceptible vertebrate hosts by the vectors. These are usually considered to be species of Culicoides biting midges but mosquitoes and/or ticks may also be involved to a greater or lesser extent. Periodically the virus makes excursions beyond its sub-Saharan enzootic zones but until recently does not appear to have been able to maintain itself outside these areas for more t...
Haemagglutination-inhibiting antibodies against African horse sickness virus in domestic animals in Nigeria. A sero-epidemiological survey of African horse sickness (AHS) virus in 261 animals which included 96 camels, 81 horses, 80 dogs and 4 donkeys was carried out in Nigeria. The animals had no history of vaccination against AHS. Sera were tested by the haemagglutination-inhibition (HI) test for the presence of antibody against AHS virus. Of these, 77 (95.1%) horse, 4 (100%) donkey, 10 (10.4%) camel and 28 (35%) dog sera samples tested were recorded as positive. The prevalence of antibody in samples taken from horses in different regions was similar. The prevalence of antibody to AHS virus detected...